ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Roswell Park Wins Competition for Organ Systems Coordinating Center

May 18, 1984

In Brief: Alice Fordyce, Supporter of Medical Research, Dead At 86; Broder Awarded Block Lectureship

September 18, 1992

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

New Grant Program To Fund Partnerships Between Academia, Industry, Non-Profits

March 14, 2003

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

NCI-Approved Clinical Trials

August 25, 2006